Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (245)
- COVID-19 (144)
- Medicines safety (140)
- Prescription medicines (124)
- Regulatory compliance (119)
- COVID-19 vaccines (86)
- Legislation (77)
- Therapeutic goods regulation (70)
- Listed medicines (48)
- Non-prescription medicines (42)
- Medical devices safety (41)
- Safety (37)
- Complementary medicines (30)
- Vaping hub (30)
- Manufacturing (26)
- Assessed listed medicines (24)
- Labelling and packaging (21)
- Medicinal cannabis hub (20)
- Over the counter (OTC) medicines (20)
- Scheduling (national classification system) (20)
- Import and export (19)
- Compliance and enforcement hub (17)
- Australian Register of Therapeutic Goods (ARTG) (16)
- Alert/Advisory (12)
- Shortages (12)
- In Vitro Diagnostic medical devices (IVDs) (10)
- Sunscreens (6)
- Weight loss products (6)
- Advisory bodies and committees (5)
- Cosmetics (3)
- Blood and blood components (2)
- Clinical trials (2)
- Fees and payments (2)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Blood safety (1)
- Breast implant hub (1)
- Registered complementary medicines (1)
- Travelling with health products (1)
Results for
"[search-keyword]"
Search
1040 result(s) found, displaying 101 to 125
-
NoticesWe have issued a notice to Pracmed Healthcare Pty Ltd to cease advertising indications related to weight loss surgery and cognitive function.
-
BlogThere has been a lot of discussion about sunscreen recently. All sunscreens that have a primary purpose of protecting against UV radiation are regulated by the TGA. They must be included in the Australian Register of Therapeutic Goods (ARTG) to be lawfully supplied in Australia
-
NewsWe are advising sponsors, who are intending to register new prescription medicines, of a new way to pursue work-sharing for priority applications.
-
NoticesWe've created a new GMP clearance Sponsor Information Dashboard (SID) to provide industry with current information about our processing times, workload and key messages. We have also updated our GMP clearance guidance.
-
NoticesFind out about how GMP clearances for manufacturing sites in Bulgaria can now be assessed via the Mutual Recognition Agreement (MRA) pathway.
-
NoticesInformation about GMP clearances issued via the MRA Pathway that expire on 31 December 2023 as well as information on the ongoing use of the GMP clearance questionnaire.
-
Safety updatesBe alert to new warnings of romosozumab (Evenity) cardiovascular risks for patients with a history of heart attack or stroke. If you're a health professional, read our Medicine safety update.
-
Media releasesIf you use a Philips Continuous Positive Airway Pressure (CPAP) machine or a Bi-level Positive Airway Pressure (Bi-Level PAP) machine you may be affected by this recall action. Register your machine for repair or replacement to avoid any potential risks.
-
BlogIf you create content, you should know how to protect yourself and your business when it comes to promoting therapeutic goods.
-
Media releasesWe have alleged that the advertising on the company's website and social media was unlawful because medicinal cannabis products are prescription-only medicines that can't be advertised directly to consumers.
-
Media releasesThe changes will help address the significant public health issues caused by vaping in Australia, while keeping legitimate patient access to therapeutic vapes.
-
BlogIf you have ever taken medicines, received an implant, had a blood transfusion or been given a vaccine, the TGA regulates those products. Did you know that the TGA also regulates some common products you’ll find in your local supermarket or health store?
-
NewsWe have launched a new search feature in the Adverse Event Management System (AEMS) portal. As a sponsor, you can access adverse event reports about your medicines and biologicals.
-
Safety updatesIf you're a health professional, get the latest information about medicines with safety related updates to their product information.
-
Media releasesWe've worked with the Australian Border Force to keep more than 307,000 units of unlawfully imported medicines and medical devices out of the Australian market.
-
Media releasesWe have issued 45 infringement notices totalling $742,500 to InstantScripts Pty Ltd for the alleged unlawful advertising of prescription-only medicines.
-
NewsIt's #MedSafetyWeek, a global movement to encourage the reporting of medicine side effects (known as ‘adverse events’). You can join in and help spread the word.
-
COVID-19 vaccine safety reportsIn line with the official end of the COVID-19 emergency response, this will be our last regular COVID-19 Vaccine Safety Report. We will continue safety monitoring of COVID-19 vaccines.
-
NoticesWe've granted a labelling exemption for the COVID-19 Vaccine, Pfizer (raxtozinameran), under the current Poisons Standard.
-
Media releasesThe Federal Court of Australia has ordered Vapor Kings Pty Ltd to pay $4.9 million for unlawfully advertising nicotine vaping products. A company Director was also ordered to pay $100,000 in penalties.
-
Media releasesWe have issued infringement notices totalling $82,632 to Ovira Pty Ltd, and an individual, for the alleged unlawful advertising of an analgesic TENS system.
-
NoticesFind out how listed medicine ingredients, and requirements for their use, have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2023.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Safety updatesRecent coronial inquiries have highlighted the need for health professionals to be alert to the well documented risk of overdose with baclofen.
-
News‘Haytox’ has not been approved by the TGA or included in the Australian Register of Therapeutic Goods (ARTG).